Plenary Session 1 - EANM'18

In Vivo Molecular Diagnosis of Cognitive Disorders – A Paradigm Change (incl. Marie Curie Lecture)


Lecture 1:
Alzheimer’s Disease Criteria: The Role of Markers of Pathology
Prof. Bruno Dubois (FR)


Lecture 2:

Amypad: A Randomized Clinical Trial to Validate the Impact of Amyloid PET
Prof. Frederik Barkhof (NL)


Lecture 3:
Marie Curie Lecture:
Tau PET Imaging: A History of Challenges and Success
Prof. Victor Villemagne (AU)



View
(1)
Plenary Session 2 - EANM'18

To Do, or Not to Do Dosimetry, that is the Question


Lecture 1:

Personalized Therapies in Oncology: Pro and Cons
Prof. Silke Gillessen (CH)


Lecture 2:

Need of Careful Personalized Dosimetric Evaluation in Radionuclide Therapy
Dr. Glenn Flux (UK)


Lecture 3: 

Dosimetry in Clinical Radionuclide Therapy: The Devil is in the Detail   
Prof. Lisa Bodei (US)



View
(2)
Plenary Session 3 - EANM'18

The Fascinating World of Molecules

Lecture 1:
The Fascinating World of Molecules
Prof. Bernard L. Feringa (NL)


Lecture 2:

Coronary Flow for Assessment of Myocardial Ischemia – The ‘Hot’ Topic in Cardiology
Prof. Jan Piek (NL)


Lecture 3:

PET to Evaluate Response to Therapy – Theranostic and Beyond
Prof. Nicolas Aide (FR)



View
(2)
Plenary Session 4 - EANM'18
Highlights Lecture

Prof. Ken Herrmann (DE)
Dr. Fijs van Leeuwen (NL)

View
(3)
Plenary Session 1 - EANM'17
Theranostic Developments for Prostate Cancer (incl. Marie Curie Lecture)

Lecture 1:
Clinical Aspects
Prof. Jochen Walz (FR)

Lecture 2:
PSMA Imaging – Which Knife is the Sharpest?
Prof. Ken Herrmann (DE)

Lecture 3:
Marie Curie Lecture: PSMA Labelled with Alfa-Emitters
Prof. Uwe Haberkorn (DE)

View
(6)
Plenary Session 2 - EANM'17
Hot Topics in Nuclear Cardiology!

Lecture 1:
Systemic Inflammatory Response Post Myocardial Ischemia: Moving Towards Clinical Application?
Prof. Dr. Erik Stroes (NL)

Lecture 2:
The Role of Nuclear Medicine in Endocarditis
Prof. Dr. Frank Bengel (DE): 

Lecture 3:
Quantification of Myocardial Blood Flow with PET
Prof. Juhani Knuuti (FI)

View
(5)
Plenary Session 3 - EANM'17
Radiobiology of Molecular Radiotherapy

Lecture 1:
DNA Damage and Repair Processes at High and Low Dose Rates
Prof. Dik van Gent (NL)

Lecture 2:
Feasibility of Non-DNA Targeted Radionuclide Therapy: Contribution of Bystander Effects
Dr. Jean-Pierre Pouget (FR)

Lecture 3:
Selective Targeting of the Cell Membrane; Attacking the Tumour House of Cards
Prof. Bryan Bednarz (US)

View
(2)
Plenary Session 4 - EANM'17
Highlights Lecture

Congress highlights, presented by Prof. Stefano Fanti (IT) and Prof. Clemens Decristoforo (AT)

View
(2)
Plenary Session 1 - EANM'16

Clinical Molecular Imaging (incl. Marie Curie Lecture)

Lecture 1: 
Guiding Therapy in Heart Disease: Role of Hybrid Imaging
P. Kaufmann (CH)

Lecture 2:
Cancer, Inflammation and the Immune System
A. Mantovani (IT)

Lecture 3: Marie Curie Lecture:
PET/CT in Malignant Lymphoma
S. Barrington (UK)



View
(1)
Plenary Session 2 - EANM'16

Radiation Facts and Figures 

Lecture 1: 
Radiation Exposure and Dose Limits: Understanding the Effects of Radionuclides for Diagnosis and Therapy
M. Lassmann (Wuerzburg)

Lecture 2:
Radiation Dose from Nuclear Medicine Procedures: A Dose of Reality
M. Stabin (Nashville)

Lecture 3:
Potential of Combined EBRT and Systemic Radionuclide Therapy
U. Nestle (Freiburg)



View
(No ranking yet)
Plenary Session 3 - EANM'16

New Developments in Cancer Imaging and Therapy

Lecture 1: 
Beyond Somatostatin Receptors: Potential for Therapy?
M. de Jong (Rotterdam)

Lecture 2:
Imaging CXCR4 in Haematologic and Solid Tumours
Andreas Konrad Buck (Würzburg)

Lecture 3:
Molecular Imaging, Image-Guided Drug Delivery, and Theranostics
W. Cai (Madison)

View
(1)
Plenary Session 4 - EANM'16
Highlights Lecture

Congress highlights, presented by F. Kraeber-Bodéré (Nantes) and E. Aboagye (London)

View
(1)
Plenary Session 1 - EANM'15

Clinical Molecular Imaging (incl. Marie Curie Lecture)

 

Lecture 1: Marie Curie Lecture:

Marie Curie Lecture: Prostate Cancer

Lecture 2:

Imaging of Atherosclerosis: Translation from Research to Practice

Lecture 3:

Neuroimaging - Mandatory Biomarker in Dementia Assessment?



View
(1)
Plenary Session 2 - EANM'15

Therapeutic Nuclear Medicine

 

Lecture 1:

Paediatric Radionuclide Therapy

Lecture 2:

Radiosynoviorthesis – State of the Art after 60 Years of Experience

Lecture 3:

Radioembolisation of Liver Metastases and HCC



View
(1)
Plenary Session 3 - EANM'15

Targets and Probes

 

Lecture 1:

Target Discovery and Probe Identifiation in Oncology

Lecture 2:

Probe Selection and Development for Molecular Imaging and Therapy, the Perspective of Industry

Lecture 3:

Probe Selection and Development for Molecular Imaging and Therapy, the Perspective of Academia




View
(1)
Plenary Session 4 - EANM'15

Highlights Lecture       

Congress highlights, presented by A.K. Buck and C. Decristoforo.



View
(1)
Plenary Session 1 - EANM'14
Therapeutic Nuclear Medicine

Lecture 1: Marie Curie Lecture:
Treatment of Differentiated Thyroid Cancer – State of the Art and New Developments
Lecture 2:

Radionuclide Treatment of Metastatic Prostate Cancer
Lecture 3:
Perspectives in the Treatment of Neuroendocrine Tumours



View
(1)
Plenary Session 2 - EANM'14
The Hybrid Age       

Lecture 1:

SPECT/CT in Bone & Joint Imaging
Lecture 2:
PET/MRI in Neurology and Psychiatry
Lecture 3:
Multimodality Imaging in Cardiology



View
(1)
Plenary Session 3 - EANM'14

Hallmarks of Cancer       

Lecture 1:
Introduction to the Hallmarks, Relation to Imaging Targets and Focus on Hypoxia

Lecture 2:
Glucose Metabolism as a Hallmark of Cancer



View
(2)
Plenary Session 4 - EANM'14
Highlights Lecture       

Congress highlights, presented by Marion de Jong, Koenraad van Laere

View
(1)
Plenary Session 1 – EANM’13

Functional and Molecular Imaging in Heart Disease
Lecture 1
- Myocardial Perfusion and Blood Flow in Clinical Decision Making (26:20)
Lecture 2 - Molecular Imaging from Bench to Bedside (26:34)



View
(1)
Plenary Session 2 – EANM’13

Use of PET in Assessment of Therapy 
Lecture 1 - FDG Standardisation (13:19)
Lecture 2 - Methods: What Tracer beyond FDG (17:35)
Lecture 3 - Therapy Evaluation: Usefulness of Tailored Treatment in Various Cancer Patients (18:55)
Lecture 4 - Therapy Evaluation: PET and Radionuclide Therapy (09:09)



View
(1)
Plenary Session 3 – EANM’13

New Insights in Molecular Neuroimaging
Lecture 1 - Cerebral Pattern Recognition in Neurodegenerative Brain Diseases using FDG Uptake and Principal Component Analysis (29:39)
Lecture 2 - Role of Molecular Imaging in the Treatment and Follow-up of Brain Tumours (21:46)



View
(1)
Highlights Lecture - EANM'13

The EANM'13 Highlights Lecture was given by F.M. Bengel and S. Fanti (39:41)

F.M. Bengel1, S. Fanti2
1Department of Nuclear Medicine, Hannover Medical School, HANNOVER, GERMANY
2Policlinico S.Orsola, University of Bologna, Radiological Sciences - Nuclear Medicine, BOLOGNA, ITAL



View
(1)
Plenary 1 Session – EANM’12
1/2 - Incorporation of FDG-PET/CT in the Evaluation of Systemic Therapy: Response Monitoring and Prediction

View
(2)
Plenary 2 Session – EANM’12
2/2 - Multimodality in Parkinson's Disease

View
(1)
Plenary 3 Session – EANM’12
3/3 - Lower Dose and Shorter Acquisition SPECT

View
(1)